Cargando…

Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?

The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be aff...

Descripción completa

Detalles Bibliográficos
Autores principales: Luna, Omar F., Gomez, Johana, Cárdenas, Constanza, Albericio, Fernando, Marshall, Sergio H., Guzmán, Fanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274427/
https://www.ncbi.nlm.nih.gov/pubmed/27854291
http://dx.doi.org/10.3390/molecules21111542
_version_ 1783377615736799232
author Luna, Omar F.
Gomez, Johana
Cárdenas, Constanza
Albericio, Fernando
Marshall, Sergio H.
Guzmán, Fanny
author_facet Luna, Omar F.
Gomez, Johana
Cárdenas, Constanza
Albericio, Fernando
Marshall, Sergio H.
Guzmán, Fanny
author_sort Luna, Omar F.
collection PubMed
description The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be affected by side reactions and by-product formation. Several aspects have to be taken into consideration when selecting a deprotection reagent: its physicochemical behavior, basicity (pKa) and polarity, concentration, and time of reaction, toxicity and disposability of residues and, finally, availability of reagents. This report presents a comparison of the performance of three strategies for deprotection using microwave-assisted Fmoc peptide synthesis. Four peptide sequences were synthesized using Rink amide resin with a Liberty Blue™ automated synthesizer and 4-methylpiperidine (4MP), piperidine (PP), and piperazine (PZ) as Fmoc removal reagents. In the first instance all three reagents behaved similarly. A detailed analysis showed a correlation between the hydrophobicity and size of the peptide with the yield and purity of the obtained product. The three reagents are interchangeable, and replacement of piperidine could be advantageous regarding toxicity and reagent handling.
format Online
Article
Text
id pubmed-6274427
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62744272018-12-28 Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? Luna, Omar F. Gomez, Johana Cárdenas, Constanza Albericio, Fernando Marshall, Sergio H. Guzmán, Fanny Molecules Article The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be affected by side reactions and by-product formation. Several aspects have to be taken into consideration when selecting a deprotection reagent: its physicochemical behavior, basicity (pKa) and polarity, concentration, and time of reaction, toxicity and disposability of residues and, finally, availability of reagents. This report presents a comparison of the performance of three strategies for deprotection using microwave-assisted Fmoc peptide synthesis. Four peptide sequences were synthesized using Rink amide resin with a Liberty Blue™ automated synthesizer and 4-methylpiperidine (4MP), piperidine (PP), and piperazine (PZ) as Fmoc removal reagents. In the first instance all three reagents behaved similarly. A detailed analysis showed a correlation between the hydrophobicity and size of the peptide with the yield and purity of the obtained product. The three reagents are interchangeable, and replacement of piperidine could be advantageous regarding toxicity and reagent handling. MDPI 2016-11-15 /pmc/articles/PMC6274427/ /pubmed/27854291 http://dx.doi.org/10.3390/molecules21111542 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Luna, Omar F.
Gomez, Johana
Cárdenas, Constanza
Albericio, Fernando
Marshall, Sergio H.
Guzmán, Fanny
Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title_full Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title_fullStr Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title_full_unstemmed Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title_short Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
title_sort deprotection reagents in fmoc solid phase peptide synthesis: moving away from piperidine?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274427/
https://www.ncbi.nlm.nih.gov/pubmed/27854291
http://dx.doi.org/10.3390/molecules21111542
work_keys_str_mv AT lunaomarf deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine
AT gomezjohana deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine
AT cardenasconstanza deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine
AT albericiofernando deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine
AT marshallsergioh deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine
AT guzmanfanny deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine